Autonomic symptoms as biomarkers in REM Sleep Behavior Disorder and Parkinson’s disease
Objective: This study was designed to evaluate autonomic functions in iRBD compared to PD and controls including longitudinal follow-up assessments to evaluate their potential to…Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease
Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study
Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in…Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats
Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…Possible correlations between symptoms suggesting gastroparesis and dyskinesias in advanced Parkinson’s disease
Objective: The objective was to describe the spectrum of gastrointestinal complaints in a large cohort of patients with advanced Parkinson’s Disease (APD), who were repeatedly…Using machine learning methods to explore gait features associated with freezing of gait in Parkinson’s Disease
Objective: To find hidden gait patterns associated with freezing of gait (FoG) in Parkinson’s disease (PD) by using machine learning techniques on the spatial and…Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?
Objective: To study the clinical onset and progression of motor manifestations in different body regions in early PD patients. Background: The vulnerability of the nigrostriatal…Alpha synuclein BAC transgenic mice as a preclinical model for disease-modifying therapies in Parkinson’s disease
Objective: The aim of this study is to make preclinical mice models for disease-modifying therapies in Parkinson's disease. Background: The prodromal stage of Parkinson's disease…Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders
Objective: To investigate the coincidence of Parkinson’s disease (PD) and schizophrenia spectrum disorders (SCD). Background: PD is characterized by a progressive loss of mesostriatal dopamine…Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study
Objective: This study evaluated the effectiveness of LCIG versus optimized medical treatment (OMT) on the duration and severity of dyskinesia in aPD patients. Background: Approximately…
- « Previous Page
- 1
- …
- 143
- 144
- 145
- 146
- 147
- …
- 149
- Next Page »